deltatrials
Completed OBSERVATIONAL NCT00281411

Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial

Follow-up Study of Endovascular Abdominal Aortic Aneurysm Treatment

Sponsor: Clinical Research Office Imaging Division

Updated 7 times since 2017 Last updated: Feb 14, 2018 Started: Mar 31, 2001 Completion: Mar 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00281411, this observational or N/A phase trial focuses on Aortic Aneurysm, Abdominal and remains completed. Sponsored by Clinical Research Office Imaging Division, it has been updated 7 times since 2001, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

The FEAT trial (Follow-up of Endovascular Aneurysm Treatment) is designed as a prospective, single-center, follow-up study. 100 Patients will be enrolled in this study. These patients will undergo additional MRA-examinations the day before EVAR, the day after EVAR, 6 months and 1 year after EVAR. These patients also participate in the conventional CTA follow-up scheme which comprises a pre- and post-operative CTA and a CTA yearly thereafter. Coagulation parameters in the blood will be measured before and 1 year after EVAR.

The FEAT trial (Follow-up of Endovascular Aneurysm Treatment) is designed as a prospective, single-center, follow-up study. 100 Patients will be enrolled in this study. These patients will undergo additional MRA-examinations the day before EVAR, the day after EVAR, 6 months and 1 year after EVAR. These patients also participate in the conventional CTA follow-up scheme which comprises a pre- and post-operative CTA and a CTA yearly thereafter. Coagulation parameters in the blood will be measured before and 1 year after EVAR.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshotUnknown Status~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

Show 2 earlier versions
  1. Mar 2018 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown StatusCompleted

  2. Jan 2017 — Mar 2018 [monthly]

    Unknown Status NA

    First recorded

Mar 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinical Research Office Imaging Division
Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations